Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 06, 2026 07:00 ET | Source: AstuteAnalytica India Pvt. Ltd.

Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market to Grow at 5.16% CAGR Through 2030 | Rising Cancer Incidence and Demand for Effective Symptom Management Drive Growth | Astute Analytica

Chicago, Feb. 06, 2026 (GLOBE NEWSWIRE) -- The global chemotherapy-induced peripheral neuropathy Market is estimated to grow at a CAGR of 5.16% during the forecast period 2022-2030 ...
September 04, 2025 08:00 ET | Source: Regen BioPharma, Inc.

Regen BioPharma Explores Expanded Use of HemaXellerate for Chemotherapy-Induced Bone Marrow Suppression

Regen’s Approach Could Be Paradigm Shift in Supportive Oncology Care SAN DIEGO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC PINK: RGBP) today announced its ongoing efforts to...
September 01, 2021 15:56 ET | Source: The Rosen Law Firm PA

ROSEN, A LEADING NATIONAL FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SPPI

NEW YORK, Sept. 01, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
May 06, 2021 09:00 ET | Source: Neuropathix, Inc.

Neuropathix, Inc. Announces Publication of Validated Preclinical Studies on KLS-13019 in the British Journal of Pharmacology

DOYLESTOWN, Pa., May 06, 2021 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced today the...